Filter posts

BIO One-On-One Partnering Kicks Off!

Partnering kicked off this today at the Business Forum at the 2013 BIO International Convention, …

Expanding Access to Orphan Drugs

At present many orphan diseases do not have any licensed treatments, and for those conditions …

Opening Up Innovation

Open Innovation has become a major theme in the life sciences over the last couple …

Our Health Care Ecosystem

There are currently 907 drugs and vaccines targeting more than 100 diseases in development by …

Legislative Hopes, Fears

Biotechnology advances are poised now more than ever to help policymakers achieve their goals of …

Session Summary: What Every CEO Must Know About IP In Biotech

On Sunday, April 21st, 2013, I attended a standing room only session titled, “What Every …

BioGENEius Challenge: The Very Real Students of BIO

With the 2013 BioGENEius Challenge underway, we’ll soon find out who will be one of the new …

Twenty Years & Counting: Welcome to Chicago!

Welcome to the 2013 BIO International Convention. It is hard to believe, but this year …

Approving Drugs for Alzheimer’s Disease

BIOtechNOW delves into the current state of Alzheimer’s disease research with today’s feature on regulatory …

Crowdfunding Goes Viral

Is crowdfunding a viable source of capital for biotech companies? μBiome thinks so; they are …